Smiley face

PJC Biomedical Students Tour MD Anderson Cancer Center

Smiley face
Touring the University of Texas MD Anderson Cancer Center in Houston were Paris Junior College students (from left) Marin Ivers, Kimberly Cox, Cameron Copeland, Cheyenne King, Wesley Giddens, and Michael Edenhoffer.

Touring the University of Texas MD Anderson Cancer Center in Houston were Paris Junior College students (from left) Marin Ivers, Kimberly Cox, Cameron Copeland, Cheyenne King, Wesley Giddens, and Michael Edenhoffer.

Six students in the biomedical and laboratory sciences program at Paris Junior College recently traveled to Houston to visit the University of Texas MD Anderson Cancer Center.

Accompanying PJC Science Division Chair Jack Brown on the trip were Marin Ivers, Kimberly Cox, Cameron Copeland, Cheyenne King, Wesley Giddens, and Michael Edenhoffer. They were among some 425 students on the tour who are interested in transferring into the MD Anderson programs.

“Each program takes only 15-30 students and PJC is still the only college that they guarantee entry for those PJC students successfully completing here,” said Brown.

During the tour students heard from the department chairs speak about their programs, what they were looking for in students, success rates, pay, job outlook and more. According to Brown, the talk was held in the AT&T Auditorium on the second floor of the hospital and so many students attended there was an overflow lecture room.

Students then broke into smaller sessions specific to the program they were interested in to get more details from the department heads and to ask questions.

During the tours each lab director explained how the lab worked, what students would learn, and how what they learn was used in the real world of medicine and beyond.

“The students were all very impressed with the university, professors, and labs – which are very advanced,” said Brown. “They like the fact that class size was just 15-30 students, depending on the program.”

Smiley face

Author: Staff Reporter

Share This Post On